Table 2 Laboratory parameters and disease severity indices in patients with cirrhosis (n = 35)
From: Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration
Parameter | Value | |
|---|---|---|
Hemoglobin (g/dL) (reference: >13.0) | 11.0 | (6.6–14.7) |
Leucocyte count (×1000/μL) (reference: 4.0–7.0) | 4.5 | (1.9–9.2) |
Platelet count (×1000/μL) (reference: 150–400) | 75.0 | (22–184) |
Serum bilirubin (mg/dL) (reference: <1.2) | 2.0 | (0.5–8.0) |
Serum aspartate transaminase (IU/L) (reference: <40) | 68.0 | (26–273) |
Serum alanine transaminase (IU/L) (reference: <40) | 40.0 | (17–162) |
Serum alkaline phosphatase (IU/L) (reference: <150) | 141.0 | (36–455) |
Serum albumin (g/dL) (reference: 3.5–5.0) | 3.4 | (2.1–4.5) |
Serum creatinine (mg/dL) (reference: <1.2) | 0.9 | (0.6–1.8) |
Prothrombin time (International normalized ratio) | 1.3 | (0.9–2.8) |
Child-Turcotte-Pugh score | 7.0 | (5–11) |
Model for end-stage liver disease (MELD) score | 13.0 | (6–25) |
Cause of liver disease | ||
Hepatitis C | 9 | |
Hepatitis B | 7 | |
Alcohol | 7 | |
Autoimmune | 1 | |
Cryptogenic | 11 | |
Child-Pugh class | ||
A | 10 | (29%) |
B | 21 | (60%) |
C | 4 | (11%) |
Clinical history | ||
Ascites | 19 | (54%) |
Spontaneous bacterial peritonitis | 6 | (32%) |
Hepatic encephalopathy | 4 | (11%) |
Variceal bleed | 8 | (23%) |